Solstein Capital LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG

Solstein Capital LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 104.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 151 shares of the medical equipment provider’s stock after buying an additional 77 shares during the quarter. Solstein Capital LLC’s holdings in Intuitive Surgical were worth $82,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in ISRG. Chilton Capital Management LLC grew its holdings in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new position in shares of Intuitive Surgical during the first quarter worth about $26,000. LFA Lugano Financial Advisors SA purchased a new position in shares of Intuitive Surgical during the first quarter worth about $30,000. TD Capital Management LLC grew its holdings in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. Finally, 1248 Management LLC purchased a new position in shares of Intuitive Surgical during the first quarter worth about $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 30,031 shares of company stock valued at $14,177,895. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.9%

Shares of NASDAQ:ISRG opened at $546.51 on Monday. The company has a market cap of $195.91 billion, a P/E ratio of 72.29, a PEG ratio of 5.02 and a beta of 1.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The company has a 50-day moving average price of $458.09 and a 200 day moving average price of $497.11.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm’s revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.84 earnings per share. Analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research reports. UBS Group set a $600.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a report on Thursday. Rothschild & Co Redburn raised their price target on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a report on Thursday. Wells Fargo & Company raised their price target on Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a report on Wednesday. Finally, Truist Financial set a $620.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $602.32.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.